Follow
Mustafa Khasraw
Mustafa Khasraw
Verified email at duke.edu
Title
Cited by
Cited by
Year
Management of glioblastoma: State of the art and future directions
AC Tan, DM Ashley, GY López, M Malinzak, HS Friedman, M Khasraw
CA: a cancer journal for clinicians 70 (4), 299-312, 2020
12482020
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
DJ McGrail, PG Pilié, NU Rashid, L Voorwerk, M Slagter, M Kok, ...
Annals of Oncology 32 (5), 661-672, 2021
6512021
Longitudinal molecular trajectories of diffuse glioma in adults
FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ...
Nature 576 (7785), 112-120, 2019
3832019
Tumor mutational burden as a predictor of immunotherapy response: is more always better?
JH Strickler, BA Hanks, M Khasraw
Clinical Cancer Research 27 (5), 1236-1241, 2021
2612021
Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance
DLH Chan, N Pavlakis, GP Schembri, EJ Bernard, E Hsiao, A Hayes, ...
Theranostics 7 (5), 1149, 2017
2392017
Epirubicin: is it like doxorubicin in breast cancer? A clinical review
M Khasraw, R Bell, C Dang
The Breast 21 (2), 142-149, 2012
2182012
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized …
A Omuro, AA Brandes, AF Carpentier, A Idbaih, DA Reardon, ...
Neuro-oncology 25 (1), 123-134, 2023
1842023
Glioma progression is shaped by genetic evolution and microenvironment interactions
FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ...
Cell 185 (12), 2184-2199. e16, 2022
1762022
Adaptive global innovative learning environment for glioblastoma: GBM AGILE
BM Alexander, S Ba, MS Berger, DA Berry, WK Cavenee, SM Chang, ...
Clinical Cancer Research 24 (4), 737-743, 2018
1702018
Advances in the treatment of malignant gliomas
M Khasraw, AB Lassman
Current oncology reports 12, 26-33, 2010
1592010
Antiangiogenic therapy for high‐grade glioma
M Khasraw, MS Ameratunga, R Grant, H Wheeler, N Pavlakis
Cochrane Database of Systematic Reviews, 2014
1582014
Anti‐angiogenic therapy for high‐grade glioma
M Ameratunga, N Pavlakis, H Wheeler, R Grant, J Simes, M Khasraw
Cochrane Database of Systematic Reviews, 2018
1412018
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
ST Garber, Y Hashimoto, SP Weathers, J Xiu, Z Gatalica, RGW Verhaak, ...
Neuro-oncology 18 (10), 1357-1366, 2016
1342016
MYCN amplification drives an aggressive form of spinal ependymoma
DR Ghasemi, M Sill, K Okonechnikov, A Korshunov, S Yip, PW Schutz, ...
Acta neuropathologica 138, 1075-1089, 2019
1242019
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Neuro-oncology 20 (7), 873-884, 2018
1232018
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry
S Gupta, T Tran, W Luo, D Phung, RL Kennedy, A Broad, D Campbell, ...
BMJ open 4 (3), e004007, 2014
1112014
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
A Omuro, TA Chan, LE Abrey, M Khasraw, AS Reiner, TJ Kaley, ...
Neuro-oncology 15 (2), 242-250, 2013
1092013
EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model
T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ...
Theranostics 5 (12), 1456, 2015
1072015
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
M Khasraw, DA Reardon, M Weller, JH Sampson
Clinical Cancer Research 26 (20), 5287-5296, 2020
992020
Neurological complications of systemic cancer
M Khasraw, JB Posner
The Lancet Neurology 9 (12), 1214-1227, 2010
982010
The system can't perform the operation now. Try again later.
Articles 1–20